DiaMedica Therapeutics

DMAC

Valor de mercado US$ 469 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Wexford Capital West Palm Beach, Florida	US$ 1,98 mi	-US$ 259 mil	-75.000	-16%
2	MHP 2 Manatuck Hill Partners Westport, Connecticut	US$ 1,33 mi	+US$ 400 mil	+115.800	+76%
3	3 Granite Point Capital Management Boston, Massachusetts	US$ 1,14 mi	+US$ 795 mil	+229.970	Nova
4	4 Worth Venture Partners Fort Lee, New Jersey	US$ 657 mil	+US$ 43,7 mil	+12.651	+11%
5	5 Millennium Management New York	US$ 493 mil	+US$ 344 mil	+99.340	Nova
6	6 Goldman Sachs New York	US$ 253 mil	+US$ 177 mil	+51.061	Nova
7	7 Eidelman Virant Capital Saint Louis, Missouri	US$ 173 mil	+US$ 121 mil	+35.000	Nova
8	8 Vanguard Group Malvern, Pennsylvania	US$ 170 mil	+US$ 118 mil	+34.238	Nova
9	9 BlackRock New York	US$ 134 mil	+US$ 57,6 mil	+16.651	+160%
10	10 UBS Group Zurich, Switzerland	US$ 11 mil	+US$ 7,78 mil	+2.250	Nova
11	11 Patriot Financial Group Insurance Agency Westborough, Massachusetts	US$ 10 mil	-US$ 3,46 mil	-1.000	-33%
12	12 Royal Bank of Canada Toronto, Ontario, Canada	US$ 10 mil	–	–	–
13	13 Bank of Montreal Toronto, Ontario, Canada	US$ 2 mil	–	–	–
14	14 FNY Investment Advisers New York	US$ 2 mil	+US$ 1,8 mil	+521	Nova
15	15 Gables Capital Management Miami, Florida	US$ 1 mil	–	–	–
16	16 Stonepine Capital Management Bend, Oregon	–	-US$ 1,14 mi	-250.000	Encerrada
17	17 Cable Hill Partners Portland, Oregon	–	-US$ 5 mil	-1.000	Encerrada
18	18 Toronto Dominion Bank Toronto, Ontario, Ontario, Canada	–	+US$ 83	+24	Nova